After the validation of CBLB knockout at the genetic and protein levels in NK cells, we aimed to check the cytotoxicity of edited NK cells against AML cells (U937 CD19tag/Luc) in vitro and compared this with wild-type cells. The gene discussed is CBLB; the disease is acute myeloid leukemia.